Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Human melanoma-associated retinopathy (MAR) antibodies alter the retinal ON-response of the monkey ERG in vivo.

Lei B, Bush RA, Milam AH, Sieving PA.

Invest Ophthalmol Vis Sci. 2000 Jan;41(1):262-6.

PMID:
10634629
2.

Treatment of paraneoplastic visual loss with intravenous immunoglobulin: report of 3 cases.

Guy J, Aptsiauri N.

Arch Ophthalmol. 1999 Apr;117(4):471-7. Review.

PMID:
10206574
3.

Cancer-associated retinopathy vs recoverin-associated retinopathy.

Keltner JL, Thirkill CE.

Am J Ophthalmol. 1998 Aug;126(2):296-302. Review. No abstract available. Erratum in: Am J Ophthalmol 1998 Dec;126(6):866.

PMID:
9727525
4.

Autoantibody-induced apoptosis as a possible mechanism of autoimmune retinopathy.

Adamus G.

Autoimmun Rev. 2003 Mar;2(2):63-8. Review.

PMID:
12848960
5.

[Paraneoplastic retinopathy and optic neuropathy].

Ikawa M, Kuriyama M.

Brain Nerve. 2010 Apr;62(4):371-6. Review. Japanese.

PMID:
20420177
6.

Paraneoplastic syndromes associated with visual loss.

Ling CP, Pavesio C.

Curr Opin Ophthalmol. 2003 Dec;14(6):426-32. Review.

PMID:
14615650
7.

[Carcinoma-associated retinopathy: a review with clinical examples].

Sobottka B, Schlote T, Besch D, Djelebova T, Wilhelm H, Zrenner E.

Klin Monbl Augenheilkd. 2000 Jan;216(1):17-24. Review. German.

PMID:
10702938
8.

Electrophysiology in the investigation of acquired retinal disorders.

Scholl HP, Zrenner E.

Surv Ophthalmol. 2000 Jul-Aug;45(1):29-47. Review.

PMID:
10946080
9.
10.

[Paraneoplastic retinal degeneration, cancer-associated retinopathy].

Kuriyama M, Fujii A, Yoneda M.

Ryoikibetsu Shokogun Shirizu. 2000;(29 Pt 4):347-50. Review. Japanese. No abstract available.

PMID:
11031966
11.

[Cancer-associated retinopathy].

Ohguro H, Takaya T, Ogawa K, Suzuki J, Nakagawa T.

Nippon Ganka Gakkai Zasshi. 1997 Apr;101(4):283-7. Review. Japanese.

PMID:
9136565
12.

[Paraneoplastic retinopathy associated with cutaneous melanoma. An update apropos of a case].

Rougier MB, Hostyn P, Bret-Dibat C, Delaunay MM, Riss I, Le Rebeller MJ.

J Fr Ophtalmol. 1995;18(5):396-403. Review. French.

PMID:
7560778
13.

Melanoma-associated paraneoplastic retinopathy: case report and review of the literature.

Boeck K, Hofmann S, Klopfer M, Ian U, Schmidt T, Engst R, Thirkill CE, Ring J.

Br J Dermatol. 1997 Sep;137(3):457-60. Review.

PMID:
9349350
14.

[Paraneoplastic retinopathy].

Liu Y, Lei B.

Zhonghua Yan Ke Za Zhi. 2012 Jul;48(7):653-6. Review. Chinese.

PMID:
22943872
15.

Calcium-binding proteins and nitric oxide in retinal function and disease.

Müller F, Koch KW.

Acta Anat (Basel). 1998;162(2-3):142-50. Review.

PMID:
9831761
16.

Acute ocular methanol toxicity: clinical and electrophysiological features.

McKellar MJ, Hidajat RR, Elder MJ.

Aust N Z J Ophthalmol. 1997 Aug;25(3):225-30. Review.

PMID:
9296298
17.

[Paraneoplastic neurologic syndrome--neoplasms and neuroimmune system].

Inuzuka T, Tanaka K.

Nihon Naika Gakkai Zasshi. 1998 Jun 10;87(6):1138-43. Review. Japanese. No abstract available.

PMID:
9702029
18.

[Cancer associated retinopathy (CAR). Two clinical cases and review of the literature].

Matus G, Dicato M, Focan C.

Rev Med Liege. 2007 Mar;62(3):166-9. Review. French.

PMID:
17511385
19.

Melanoma-associated retinopathy: does autoimmunity prolong survival?

Chan C, O'Day J.

Clin Exp Ophthalmol. 2001 Aug;29(4):235-8. Review.

PMID:
11545422
20.

Ocular manifestations of cancer.

De Potter P.

Curr Opin Ophthalmol. 1998 Dec;9(6):100-4. Review.

PMID:
10387328

Supplemental Content

Support Center